ESM file 9 from Identification of reactive intermediate formation and bioactivation pathways in Abemaciclib metabolism by LC–MS/MS: <i>in vitro</i> metabolic investigation
These mass spec ion counts pertaining to data refer to Fig. 3E and Fig. S3H of our manuscript PARP-inhibition reprograms macrophages towards an anti-tumor phenotype; CELL-REPORTS-D-21-05754R2
